UCL Institute of Ophthalmology
EyeTherapy information hub
- Sight loss conditions we are developing treatments for
- How we design gene and cell therapies
- Current clinical trials of gene and cell therapy for sight loss
- How to get involved with our research
Current clinical trials of gene and cell therapy for sight loss
We are currently conducting two ground-breaking clinical trials:
The world's first gene therapy trial in the eye, testing the safety and efficacy of delivering the RPE65 gene to the eyes of patients with Leber congenital amaurosis.
Europe's first trial testing the safety of transplanting stem cell-derived retinal cells into the eyes of patients with Stargardt disease.
Page last modified on 09 aug 12 13:27